Basal Ganglia

Introduction to Basal Ganglia

  • Basal ganglia are a crucial set of brain structures that regulate movement.

  • Located deep within the cerebral hemispheres, lateral to the thalamus, and in the anterior midbrain.

  • They do not initiate movement like the motor cortex and cerebellum, but rather modulate movement by influencing motor circuits in the brain.

Organization of Basal Ganglia

Main Components

  • Striatum: Orange structure

    • Consists of:

      • Caudate

      • Putamen

  • Pallidum: Purple structure

    • Composed of:

      • Globus pallidus

      • Substantia nigra pars reticulata

  • Subthalamic nucleus: Light green structure

Functional Differences

  • Striatum processes input signals and sends refined information to the pallidum.

  • Pallidum exerts strong inhibitory control over higher motor centers, ensuring smooth and precise movement.

Striatum Overview

  • Contains approximately 100 million neurons (75% medium spiny neurons).

  • Medium spiny neurons have large dendritic trees for collecting input from various sources:

    • Cerebral cortex

    • Local circuit interneurons (within striatum)

    • Thalamus (midline nuclei)

    • Brainstem (substantia nigra pars compacta)

  • Functional Features of Medium Spiny Neurons:

    • GABAergic (inhibitory)

    • Receive dopaminergic inputs from substantia nigra

    • Possess inward rectified potassium channels, influencing excitability

Dopaminergic Modulation

  • D1 Receptors:

    • Activate G proteins, increase cAMP, enhance GABA release, facilitating movement.

  • D2 Receptors:

    • Decrease cAMP, suppress GABA release, leading to inhibition in movement.

Medium Spiny Neurons

  • Require strong excitatory inputs to trigger action potentials due to negative resting membrane potential (-85/-88 mV).

  • Increase firing rates before movements indicate their role in encoding movement decisions instead of movement execution specifics.

Pallidum Overview

Neuronal Characteristics

  • Contains approximately 700,000 inhibitory GABAergic neurons.

  • High levels of spontaneous activity prevent unwanted movements by tonically inhibiting thalamus and superior colliculus.

  • More than 100 median spiny neurons innervate each cell in globus pallidus, contrasting the striatum's larger neuron population.

Projection Pathways

Inputs to the Striatum

  • Corticostriatal Pathway: Cortical input to striatum.

  • Thalamostriatal Pathway: Input from the thalamus.

  • Dopaminergic Input: From substantia nigra pars compacta.

Differentiation of Projections

  • Caudate receives projections primarily from the frontal motor area.

  • Putamen receives inputs from multiple cortical areas, including motor and somatosensory cortices.

Output from the Basal Ganglia

Pathways Involved

  • Direct Pathway: Striatum → Internal globus pallidus → Thalamus

    • Facilitates movement by disinhibiting thalamic activity.

  • Indirect Pathway: Striatum → External globus pallidus → Subthalamic nucleus → Internal globus pallidus

    • Suppresses movement by enhancing inhibitory output.

Mechanisms of Action

  • Firing of striatal neurons inhibits globus pallidus, leading to thalamic disinhibition and activation of upper motor neurons, which initiates movement.

  • Balancing the direct and indirect pathways is crucial for smooth motor control.

Contribution to Movement Control

Example: Saccadic Eye Movement

  • Basal ganglia play a role in eye movement control via inputs from the substantia nigra to the superior colliculus.

  • Saccade initiation involves reduction in activity from the substantia nigra that facilitates activation of upper motor neurons.

Movement Disorders Associated with Basal Ganglia Dysfunction

Types of Disorders

  • Hyperkinetic Disorders: Excessive movement (e.g., Huntington's disease).

  • Hypokinetic Disorders: Reduced movement (e.g., Parkinson's disease).

Parkinson's Disease

  • Caused by loss of dopaminergic neurons in the substantia nigra.

  • Results in reduced movement initiation and control due to overactivity of the indirect pathway.

  • Symptoms include bradykinesia, tremors, rigidity, and postural instability.

  • Treatment includes Levodopa therapy and deep brain stimulation.

Huntington's Disease

  • Genetic degeneration of motor neurons in the indirect pathway.

  • Loss of inhibition leads to excess thalamic activation and uncontrolled movements (chorea).

  • Symptoms: involuntary movements, cognitive decline, and emotional disturbances.

Treatment Options for Basal Ganglia Disorders

Current Therapeutic Approaches

  • Symptom Management: Focus of treatments for both Parkinson's and Huntington's diseases.

  • Deep Brain Stimulation (DBS): Invasive procedure involving implantation of electrodes to modulate brain activity.

    • Targets areas like the globus pallidus internal segment and subthalamic nucleus.

    • Requires careful adjustment for optimal results.

    • Efficacy varies; more research is needed on mechanisms and outcomes.

Future Directions

  • Ongoing studies emphasize animal models to understand disease progression and treatment efficacy.

  • Innovations in treatments are necessary to provide effective solutions for these neurological disorders.